PT144.S1.P2.Q7 > Analytics

Hide analysis

The following passage was adapted from a law journal article published in 1998.

██████████ ████ ███ █████████████ ███ █████████ ████ ████████████ ████████ ██████████ ██████ ██ █████████ ███ ███████████ ████ ████ ████ ████████ ███ ████ ██████████ ██████████ █████████████ ███████████ ██ ████████ ████████████ ████████████ █████ ████ ████ ███████ ██ █████ ████████ ██ ████████ ███████ ████ ██ ██ ████ ███████████ ██ ███ █████████████ ██ █████ ████████ ████████ █████████ █████ ███ ██████ ██ █████ █████████████ █████████ ██ █████████ █████ ████████ ████ ████████ ████ ██ ███ █████ ███ ███ █████████ ███ █████████████████ ██ █████████████ ██████████ ███ ███ ███ █████ ██ █████████ ████████ ██ ██████████ ███ ██████ ███████

Intro topic · Intellectual property protection for biotech discoveries

Both industries and academia support protection.

████ ███████████ ████ ████ █████████ ██████████ █████████ ████ ██████ ██ ███ ██████ ████████ ██████████ ██ ███████████ ██ ██████ ███████ ████████ ███████ █ █████ ██████ ███ ██████ █████████████ ██ █████ ██████████ █ ██████ ██████ ██ ███ █████ ██ ██████████ █████████ ███ ██████ ██ ████ ████ █████████ █████████ ██ ██████████ ██████████ █████ ████████ ██████ █ ██████ ██████████████████ █████████ ██ ███████ █████████ ██ ███████████ ███ ████████ ███ ██████ ██ █ ██████ ██ ██████ ██████████ █████████ ███ ████ ██ ███████ █ ███████ ██ ████████████ ███ ███ █████ ████████ ██ ███ ████████ ██ ███ █████████ ████████ ███████████ ███ ██████ █████████████ ███████ ████ ████ █████████ ██████ ███████ ████ ██████ █████████████ ████ ████ ███ ███ █████ ██ ███████ █████ ████████ █████████ ███ ███ ██ ████████ ██████████

Question · How much does patenting in biotech hinder basic research?

Other people's (OP) perspective · Patents hinder basic research through enforcement of patent rights or through contractual agreements

This isn't necessarily the author's view, because of the phrase "perceived threat." We're getting other people's perception of the threat.

████ ██████████ ██████ ████ ████████ █ ██████ ███████ ████████ ███ █████ ██ ████ ███████ ███

Potential way patents slow research · Patent infringement

Patent holders might sue or threaten to sue researchers who use patented biological materials.

██ ████████ ███████ █ ██████ █████ ██ █████ ██ ████████ ███████ █ ███████████ ████████████ ███ ██████████ █████ ███ █████████████ █████████ ██ █████████████ ██████ ██████ ██████████ ██ ██ █████████ ████████ ███ ███ ███████ █████████ ████ ██ ███████ █ ██████ ████████ ████████ ██ ███ ██████ ██████ ██ ██ █████████ ██████ █████████ ███████ █████ ███ ████ █ █████████ █████ ██████ ████████ ██████ █████ ██ ███████ █ ██████████ █████████████ ████████ █████████ ██ ██████ █████████████ █████████ ██ ██ ██████ ████ ███████ ████ ████████ ████ ██████ ████ ██████ █████ █████████ ███████ ███████ ███████ ██████████ ████ █ ██████████ █████████ ██ █████████ ███████████ ████ ████ ███████ █████ ████████ ███████ ██ ████ ██ █ ██████ ██ █████████ ███████ ████ ███ ███ ██ █████ ████████████

Potential way patents slow research · Contractual agreements

Patent holders might charge researchers incredibly high fees or want other benefits in return for allowing use of patented biological materials.

Passage Style

Critique or debate

Problem-analysis

Which one of the following ████ ██████████ █████████ ███ ████ █████ ██ ███ ████████

Question Type

Main point

The author explores the question of whether discoveries from biotechnology research should be patentable. After presenting the perspective of some researchers who think it shouldn’t be patentable, the author presents her own opinion — patents are unlikely to be as restrictive as researchers fear, and may even help promote research. The main point should capture the author’s own opinion.

By commercializing the ████████ ███████████ █████████████ ███████ ████████ ███ ████████ ██ █████ ████████ ██ ███ ██████████ █████████

This doesn’t capture the author’s opinion, which is that biotechnology patents are unlikely to threaten the progress of basic research.

The recent shift ████ ████ █ ████████ █████████ ███ ██████ █ █████████████ ████████ ██ █████ ██████████ ████████ ███ ██████ ███████████ █████ ███████████

This doesn’t capture the author’s own opinion about biotechnology patents. The main point isn’t just that there’s a debate; the main point is that those who think patents will severely restrict research are likely not correct.

The current system ██ ██████ ██████████ ███ ████████████ ████████ ████████ █████████ ████ ████████ ███████████ ███ ██████████ ██████████

The author’s main point isn’t critical of the current system of patent protection. So the main point wouldn’t be that the current system is “unfair.”

Concerns expressed by ████████ ███████████ ████ █████████████ ███████ ████ ██████████ ██████ █████ ███████ ██ ███████ █████ ████████ ███ ███████ ██████████

This best captures the author’s opinion, which is that her own opinionpatents are unlikely to be as restrictive as researchers fear, and may even help promote research

89%

Patent litigation is ██ █████████ ████ █████████████ ██████ ███████ ███ ████████ ██ █████ ███████████████████ ████████ ███████ ██████████ ███████ ██ █████ █████████

This is too narrow to be the main point. The author does use the expense of patent litigation as a supporting point, but the broader point that it supports is the idea that patents won’t be as restrictive to research as some scientists think.

PrepTest 144 - Section 1 - Passage 2 - Question 7

Difficulty

Analysis

Answer Popularity

Question history

Answer five questions and we'll estimate your score.

Confirm action